This compound is a deuterium-labeled pharmaceutical intermediate used in the manufacturing process of alogliptin. Its structure features a pyrimidinedione core with a 3-aminopiperidinyl substituent and a benzonitrile group.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N-Desmethyl,N-2(2-cyanobenzyl) Alogliptin
research compound
2-(Phenylthio)aniline
pharmaceutical intermediate
(6R,7R)-7-Amino-3-(chloromethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (4-methoxyphenyl)methyl ester hydrochloride
pharmaceutical intermediate
N-cyclohexylcyclohexanamine;5-fluoro-2-oxo-1H-pyrazine-3-carbonitrile
pharmaceutical intermediate
N-benzyloxycarbonylglycine
pharmaceutical intermediate
Alogliptin (13CD3)
pharmaceutical raw material
(S)-Alogliptin Benzoate Salt
pharmaceutical raw material
Alogliptin
pharmaceutical raw material
2-[[6-[(3R)-3-aminopiperidin-1-yl]-2,4-dioxo-3-(trideuteriomethyl)pyrimidin-1-yl]methyl]benzonitrile
ZSBOMTDTBDDKMP-DDOHFVCQSA-N
[2H]C([2H])([2H])N1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)N
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.